X-linked recessive ocular albinism

X-linked recessive ocular albinism, also known as ocular albinism type 1 (OA1) or Nettleship-Falls ocular albinism, is a genetic condition primarily affecting the eyes. It is caused by mutations in the GPR143 gene (formerly called the OA1 gene) located on the X chromosome. Because it follows an X-linked recessive inheritance pattern, it predominantly affects males, while females are typically carriers who may show mild or subtle signs of the condition. The hallmark features of X-linked recessive ocular albinism involve the visual system. Affected individuals have reduced pigmentation (hypopigmentation) of the iris and retina, leading to characteristic findings such as iris translucency, foveal hypoplasia (underdevelopment of the central part of the retina responsible for sharp vision), and misrouting of the optic nerve fibers at the optic chiasm. These abnormalities result in significantly reduced visual acuity, nystagmus (involuntary rhythmic eye movements), and photophobia (sensitivity to light). Strabismus (misalignment of the eyes) is also common. Unlike oculocutaneous albinism, skin and hair pigmentation in affected males is generally normal or near-normal, although it may be slightly lighter than that of unaffected family members. Female carriers often demonstrate a characteristic mosaic pattern of retinal pigmentation (a "mud-splattered" fundus appearance) on ophthalmologic examination. There is currently no cure for X-linked recessive ocular albinism. Management is supportive and focuses on optimizing visual function. This includes prescription of corrective lenses, use of low-vision aids, tinted lenses or sunglasses to manage photophobia, and treatment of strabismus with patching, prisms, or surgery when indicated. Regular ophthalmologic follow-up is recommended throughout life. Genetic counseling is important for affected families to understand recurrence risks and carrier status.

Common questions about X-linked recessive ocular albinism